Skip to content

MEDIBELAROM: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDIBELAROM

BE 0640.975.604
NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€726
2024 · -€646+€1,371
Equity
€22,612
2024 · €21,886+€726
Cash
€20,560
2024 · €20,611-€52
Balance sheet total
€23,292
2024 · €21,991+€1,302

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€1,153

    new in 2025: €1,153

Equity and liabilities
  • Profit (loss) carried forward +€726

    up €726 (+49.0%), from €1,481 to €2,207

  • Trade debts +€565

    up €565 (+635%), from €89 to €654

Income statement
  • Other operating charges -€776

    down €776 (-59.6%), from €1,301 to €526

  • Gross operating margin +€647

    up €647 (+97.4%), from €664 to €1,311

  • Depreciation +€33

    new in 2025: €33

  • Taxes +€18

    up €18 (+217%), from €8 to €27

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€646
Gross operating margin +€647
Depreciation -€33
Other operating charges +€776
Taxes -€18
Result 2025 €726
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1,134
Investment -€1,186
Financing €0
Cash 2024 €20,611
Net result for the year +€726
Depreciation +€33
Receivables within one year -€201
Trade debts +€565
Tax, wage and social debts +€27
Other debts -€16
Investment in fixed assets (net) -€1,186
Cash 2025 €20,560
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €21,991 €23,292 +€1,302 +5.9%
Fixed assets 21/28 - €1,153 +€1,153
Tangible fixed assets 22/27 - €1,153 +€1,153
Furniture and vehicles 24 - €1,153 +€1,153
Current assets 29/58 €21,991 €22,139 +€149 +0.7%
Stocks and contracts in progress 3 €1,379 €1,379 = 0.0%
Stocks 30/36 €1,379 €1,379 = 0.0%
Amounts receivable within one year 40/41 €0 €201 +€201 +71,611%
Trade receivables 40 €0 €0 = 0.0%
Other amounts receivable 41 - €201 +€201
Cash at bank and in hand 54/58 €20,611 €20,560 -€52 -0.3%
Total equity and liabilities 10/49 €21,991 €23,292 +€1,302 +5.9%
Equity 10/15 €21,886 €22,612 +€726 +3.3%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €1,855 €1,855 = 0.0%
Non-distributable reserves 130/1 €1,855 €1,855 = 0.0%
Reserves not available under the articles 1311 €1,855 €1,855 = 0.0%
Profit (loss) carried forward 14 €1,481 €2,207 +€726 +49.0%
Amounts payable 17/49 €105 €681 +€576 +551%
Amounts payable within one year 42/48 €105 €681 +€576 +551%
Trade debts 44 €89 €654 +€565 +635%
Suppliers 440/4 €89 €654 +€565 +635%
Taxes, remuneration and social security 45 - €27 +€27
Taxes 450/3 - €27 +€27
Other amounts payable 47/48 €16 - -€16
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €33 +€33
Other operating charges 640/8 €1,301 €526 -€776 -59.6%
Gross operating margin 9900 €664 €1,311 +€647 +97.4%
Operating profit (loss) 9901 -€637 €752 +€1,390
Profit (loss) for the period before taxes 9903 -€637 €752 +€1,390
Income taxes 67/77 €8 €27 +€18 +217%
Profit (loss) for the period 9904 -€646 €726 +€1,371
Profit (loss) for the period to be appropriated 9905 -€646 €726 +€1,371

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.